{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T18:46:40Z","timestamp":1786387600455,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103970"],"award-info":[{"award-number":["82103970"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences & Peking Union Medical College","doi-asserted-by":"publisher","award":["2023-I2M-2-001"],"award-info":[{"award-number":["2023-I2M-2-001"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences & Peking Union Medical College","doi-asserted-by":"publisher","award":["2021-I2M-1-030"],"award-info":[{"award-number":["2021-I2M-1-030"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences & Peking Union Medical College","doi-asserted-by":"publisher","award":["2018PT35026"],"award-info":[{"award-number":["2018PT35026"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bioorg.2025.109016","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T04:09:13Z","timestamp":1758686953000},"page":"109016","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Optimization of pyrrole-2-carboxamide to develop a potent antituberculosis agent with improved physicochemical property and druggability"],"prefix":"10.1016","volume":"165","author":[{"given":"Yanan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.109016_bb0005","series-title":"Global Tuberculosis Report","author":"World Health Organization","year":"2024"},{"key":"10.1016\/j.bioorg.2025.109016_bb0010","doi-asserted-by":"crossref","first-page":"11241","DOI":"10.1073\/pnas.1901346116","article-title":"MmpL3 is a lipid transporter that binds trehalose monomycolate and phosphatidylethanolamine","volume":"116","author":"Su","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2025.109016_bb0015","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nchembio.794","article-title":"Inhibition of mycolic acid transport across the mycobacterium tuberculosis plasma membrane","volume":"8","author":"Grzegorzewicz","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bioorg.2025.109016_bb0020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/mdr.2021.0239","article-title":"The gene and regulatory network involved in ethambutol resistance in mycobacterium tuberculosis","volume":"29","author":"Boni","year":"2023","journal-title":"Microb. Drug Resist."},{"key":"10.1016\/j.bioorg.2025.109016_bb0025","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.cell.2019.01.003","article-title":"Crystal structures of membrane transporter MmpL3, an anti-TB drug target","volume":"176","author":"Zhang","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2025.109016_bb0030","doi-asserted-by":"crossref","first-page":"4426","DOI":"10.1016\/j.jmb.2020.05.019","article-title":"Structural basis for the inhibition of mycobacterial MmpL3 by NITD-349 and SPIRO","volume":"432","author":"Yang","year":"2020","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bioorg.2025.109016_bb0035","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1128\/AAC.00826-16","article-title":"Therapeutic potential of the mycobacterium tuberculosis mycolic acid transporter, MmpL3","volume":"60","author":"Li","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2025.109016_bb0040","doi-asserted-by":"crossref","DOI":"10.1038\/srep43495","article-title":"Essentiality of MmpL3 and impact of its silencing on mycobacterium tuberculosis gene expression","volume":"7","author":"Degiacomi","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.109016_bb0045","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00629-19","article-title":"Utilization of CRISPR interference to validate MmpL3 as a drug target in mycobacterium tuberculosis","volume":"63","author":"McNeil","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2025.109016_bb0050","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/jac\/dkab437","article-title":"Utilization of CRISPR interference to investigate the contribution of genes to pathogenesis in a macrophage model of mycobacterium tuberculosis infection","volume":"77","author":"Cheung","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bioorg.2025.109016_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112390","article-title":"MmpL3 inhibitors as antituberculosis drugs","volume":"200","author":"Shao","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109016_bb0060","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/cmdc.202100359","article-title":"Mycobacterial membrane protein large 3 (MmpL3) inhibitors: a promising approach to combat tuberculosis","volume":"16","author":"Umare","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2025.109016_bb0065","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1080\/17460441.2023.2218082","article-title":"Recent advances in mycobacterial membrane protein large 3 inhibitor drug design for mycobacterial infections","volume":"18","author":"North","year":"2023","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bioorg.2025.109016_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115351","article-title":"Structure-directed identification of pyridine-2-methylamine derivatives as MmpL3 inhibitors for use as antitubercular agents","volume":"255","author":"Wen","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109016_bb0075","article-title":"Design, synthesis, biological evaluation study of spirocyclic POM analogues as novel MmpL3 anti-tubercular agent","volume":"153","author":"Kim","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109016_bb0080","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/jac\/dku553","article-title":"On behalf of the Pan African consortium for the evaluation of Antituberculosis antibiotics (PanACEA), early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients","volume":"70","author":"Heinrich","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bioorg.2025.109016_bb0085","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.3390\/biomedicines10112793","article-title":"MmpL3 inhibition as a promising approach to develop novel therapies against tuberculosis: a spotlight on SQ109, clinical studies, and patents literature","volume":"10","author":"Imran","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.bioorg.2025.109016_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104486","article-title":"Design, synthesis and antimycobacterial evaluation of novel adamantane and adamantanol analogues effective against drug-resistant tuberculosis","volume":"106","author":"Alsayed","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109016_bb0095","doi-asserted-by":"crossref","first-page":"10534","DOI":"10.1021\/acs.jmedchem.2c00718","article-title":"Design, synthesis, and biological evaluation of pyrrole-2-carboxamide derivatives as mycobacterial membrane protein large 3 inhibitors for treating drug-resistant tuberculosis","volume":"65","author":"Zhao","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109016_bb0100","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/17460441.2021.1918096","article-title":"Artificial intelligence in early drug discovery enabling precision medicine","volume":"16","author":"Boniolo","year":"2021","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bioorg.2025.109016_bb0105","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.1016\/j.tetlet.2015.09.057","article-title":"Facile preparation of 3-substituted-2,6-difluoropyridines: application to the synthesis of 2,3,6-trisubstituted pyridines","volume":"56","author":"Katoh","year":"2015","journal-title":"Tetrahedron Lett."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682500896X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682500896X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T20:35:45Z","timestamp":1760560545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004520682500896X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":21,"alternative-id":["S004520682500896X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109016","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimization of pyrrole-2-carboxamide to develop a potent antituberculosis agent with improved physicochemical property and druggability","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109016"}}